Cargando…
Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma
Telomerase reverse transcriptase (TERT) promoter mutations are among the most frequent noncoding somatic mutations in multiple cancers, including hepatocellular carcinoma (HCC). The clinical and pathological implications of TERT promoter mutations in hepatitis B virus (HBV)-associated HCC have not b...
Autores principales: | Yang, Xunjun, Guo, Xiuchan, Chen, Yao, Chen, Guorong, Ma, Yin, Huang, Kate, Zhang, Yuning, Zhao, Qiongya, Winkler, Cheryl A., An, Ping, Lyu, Jianxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053691/ https://www.ncbi.nlm.nih.gov/pubmed/27056898 http://dx.doi.org/10.18632/oncotarget.8539 |
Ejemplares similares
-
Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2021) -
Impacts of the SOAT1 genetic variants and protein expression on HBV-related hepatocellular carcinoma
por: Chen, Yulong, et al.
Publicado: (2021) -
Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma
por: Sze, Karen Man‐Fong, et al.
Publicado: (2020) -
Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma
por: Toshikuni, N, et al.
Publicado: (2000) -
Telomerase reverse transcriptase and neurodegenerative diseases
por: Yu, Xin, et al.
Publicado: (2023)